Comparison of Oxaliplatin- and Cisplatin-Induced Painful Peripheral Neuropathy in the Rat

Journal of Pain

Volumn 10, Issue 5, 2009, Pages 534-541

  Joseph, Elizabeth K ^a   Levine, Jon D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; cisplatin; neuropathy; oxaliplatin

Indexed keywords

ANTIOXIDANT; CASPASE; CASPASE INHIBITOR; CISPLATIN; OXALIPLATIN;

ALLODYNIA; ANIMAL EXPERIMENT; ARTICLE; COLD; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; HYPERALGESIA; LATENT PERIOD; MALE; MITOCHONDRION; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NEUROPATHY; RAT; RESPIRATORY CHAIN; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BEHAVIOR, ANIMAL; CASPASES; CISPLATIN; COLD TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT; HOT TEMPERATURE; HYPERALGESIA; MALE; MITOCHONDRIA; ORGANOPLATINUM COMPOUNDS; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 67349144101     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.12.003     Document Type: Article

References (49)

1. Abrey L.E., and Correa D.D. Treatment-related neurotoxicity. Hematol Oncol Clin North Am 19 (2005) 729-738
2. Adelsberger H., Quasthoff S., Grosskreutz J., Lepier A., Eckel F., and Lersch C. The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons. Eur J Pharmacol 406 (2000) 25-32
3. Aley K.O., and Levine J.D. Role of protein kinase A in the maintenance of inflammatory pain. J Neurosci 19 (1999) 2181-2186
4. Aley K.O., and Levine J.D. Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience 111 (2002) 389-397
5. Aley K.O., Martin A., McMahon T., Mok J., Levine J.D., and Messing R.O. Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci 21 (2001) 6933-6939
6. Aley K.O., Reichling D.B., and Levine J.D. Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans. Neuroscience 73 (1996) 259-265
7. Bhagra A., and Rao R.D. Chemotherapy-induced neuropathy. Curr Oncol Rep 9 (2007) 290-299
8. Binder A., Stengel M., Maag R., Wasner G., Schoch R., Moosig F., Schommer B., and Baron R. Pain in oxaliplatin-induced neuropathy: Sensitisation in the peripheral and central nociceptive system. Eur J Cancer 43 (2007) 2658-2663
9. Cadenas E., Boveris A., Ragan C.I., and Stoppani A.O. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch Biochem Biophys 180 (1977) 248-257
10. Cavenagh J., Good P., and Ravenscroft P. Neuropathic pain: Are we out of the woods yet?. Intern Med J 36 (2006) 251-255
11. Cersosimo R.J. Oxaliplatin-associated neuropathy: A review. Ann Pharmacother 39 (2005) 128-135
12. Culy C.R., Clemett D., and Wiseman L.R. oxaliplatin: A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. Drugs 60 (2000) 895-924
13. Eastman A. Alkylating and platinum-based agents. Curr Opin Oncol 2 (1990) 1109-1114
14. Extra J.M., Marty M., Brienza S., and Misset J.L. Pharmacokinetics and safety profile of oxaliplatin. Semin Oncol 25 (2005) 13-22
15. Flatters S.J., and Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction. Pain 122 (2006) 245-257
16. Fuse N., Doi T., Ohtsu A., Takeuchi S., Kojima T., Taku K., Tahara M., Muto M., Asaka M., and Yoshida S. Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer. Jpn J Clin Oncol 37 (2007) 434-439
17. Gamelin E., Gamelin L., Bossi L., and Quasthoff S. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures. Semin Oncol 29 (2002) 21-33
18. Garrido N., Perez-Martos A., Faro M., Lou-Bonafonte J.M., Fernandez-Silva P., Lopez-Perez M.J., Montoya J., and Enriquez J.A. cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels. Biochem J 414 (2008) 93-102
19. Goodisman J., Hagrman D., Tacka K.A., and Souid A.K. Analysis of cytotoxicities of platinum compounds. Cancer Chemother Pharmacol 57 (2006) 257-267
20. Grothey A. Oxaliplatin-safety profile: Neurotoxicity. Semin Oncol 30 (2003) 5-13
21. Haller D.G. Safety of oxaliplatin in the treatment of colorectal cancer. Oncology (Williston Park) 14 (2000) 15-20
22. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
23. Heaney M.L., Gardner J.R., Karasavvas N., Golde D.W., Scheinberg D.A., Smith E.A., and O'Connor O.A. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res 68 (2008) 8031-8038
24. Joseph E.K., Chen X., Bogen O., and Levine J.D. oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 9 (2008) 463-472
25. Joseph E.K., Chen X., Khasar S.G., and Levine J.D. Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain 107 (2004) 147-158
26. Joseph E.K., and Levine J.D. Caspase signalling in neuropathic and inflammatory pain in the rat. Eur J Neurosci 20 (2004) 2896-2902
27. Joseph E.K., and Levine J.D. Mitochondrial electron transport in models of neuropathic and inflammatory pain. Pain 121 (2006) 105-114
28. Kannarkat G., Lasher E.E., and Schiff D. Neurologic complications of chemotherapy agents. Curr Opin Neurol 20 (2007) 719-725
29. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7 (2007) 573-584
30. Kiernan M.C., and Krishnan A.V. The pathophysiology of oxaliplatin-induced neurotoxicity. Curr Med Chem 13 (2006) 2901-2907
31. Kim C.H., Kang S.U., Pyun J., Lee M.H., Hwang H.S., and Lee H. Epicatechin protects auditory cells against cisplatin-induced death. Apoptosis 13 (2008) 1184-1194
32. Kinnman E., and Levine J.D. Involvement of the sympathetic postganglionic neuron in capsaicin-induced secondary hyperalgesia in the rat. Neuroscience 65 (1995) 283-291
33. Korshunov S.S., Skulachev V.P., and Starkov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416 (1997) 15-18
34. Krishnan A.V., Goldstein D., Friedlander M., and Kiernan M.C. oxaliplatin-induced neurotoxicity and the development of neuropathy. Muscle Nerve 32 (2005) 51-60
35. Krishnan A.V., Goldstein D., Friedlander M., and Kiernan M.C. oxaliplatin and axonal Na+ channel function in vivo. Clin Cancer Res 12 (2006) 4481-4484
36. Lehky T.J., Leonard G.D., Wilson R.H., Grem J.L., and Floeter M.K. oxaliplatin-induced neurotoxicity: Acute hyperexcitability and chronic neuropathy. Muscle Nerve 29 (2004) 387-392
37. McKeage M.J., Hsu T., Screnci D., Haddad G., and Baguley B.C. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer 85 (2001) 1219-1225
38. Melli G., Taiana M., Camozzi F., Triolo D., Podini P., Quattrini A., Taroni F., and Lauria G. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol 214 (2008) 276-284
39. Murata M., Yamaji Y., Futami H., Shimada Y., Fujita J., Hashimoto Y., Shiotani T., and Irino S. [Peripheral neuropathy caused by cisplatin in patients with lung cancer]. Gan To Kagaku Ryoho 16 (1989) 2283-2288
40. Osio M., Muscia F., Zampini L., Nascimbene C., Mailland E., Cargnel A., and Mariani C. Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: An open label study. J Periph Nerv Syst 11 (2006) 72-76
41. Pan Y., and Kao M.S. Discordance of clinical symptoms and electrophysiologic findings in taxane plus platinum-induced neuropathy. Int J Gynecol Cancer 17 (2007) 394-397
42. Reed E. Alkylating agents and platinum: Is clinical resistance simply a tumor cell phenomenon?. Curr Opin Oncol 3 (1991) 1055-1059
43. Rosenberg B. Noble metal complexes in cancer chemotherapy. Adv Exp Med Biol 91 (1997) 129-150
44. Saarto T, Wiffen PJ: Antidepressants for neuropathic pain. Cochrane Database Syst Rev CD005454, 2007
45. Shaiova L. Difficult pain syndromes: Bone pain, visceral pain, and neuropathic pain. Cancer J 12 (2006) 330-340
46. Stillman M., and Cata J.P. Management of chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 10 (2006) 279-287
47. Sul J.K., and Deangelis L.M. Neurologic complications of cancer chemotherapy. Semin Oncol 33 (2006) 324-332
48. Tournigand C., Andre T., Achille E., Lledo G., Flesh M., Mery-Mignard D., Quinaux E., Couteau C., Buyse M., Ganem G., Landi B., Colin P., Louvet C., and de Gramont A. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 22 (2004) 229-237
49. Wallace J.M. Update on pharmacotherapy guidelines for treatment of neuropathic pain. Curr Pain Headache Rep 11 (2007) 208-214